You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 147 No. 8, August 1987 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (44)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Captopril Reduces Urinary Cystine Excretion in Cystinuria

James A. Sloand, MD; Joseph L. Izzo, Jr, MD

Arch Intern Med. 1987;147(8):1409-1412.


Abstract

• Cystinuria is characterized by cystine stone formation and loss of renal function. Conservative therapy is generally ineffective and penicillamine therapy can be complicated by serious side effects. To our knowledge, we report the first clinical use of captopril in the treatment of homozygous cystinuria in two siblings. In the first patient, a 70% reduction in cystine excretion was observed after 26 weeks of therapy with 150 mg/d of captopril. Discontinuation of use of the drug resulted in a return to baseline cystine excretion, further loss of renal function, and nephrotic range proteinuria. Repeated treatment with captopril stabilized renal function, reduced proteinuria, and returned cystine excretion to near normal levels. In the second patient, cystine excretion was reduced by 93% after nine weeks of therapy with 75 mg/d of captopril. No adverse side effects were observed in either patient. Formation of the captopril–cysteine disulfide accounts for part of the reduction in cystine excretion but other mechanisms probably contribute. Because captopril–cysteine disulfide is 200 times more soluble than cystine, long-term captopril therapy may be useful in the treatment of cystinuria.

(Arch Intern Med 1987;147:1409-1412)



Author Affiliations

From the Nephrology Division, Department of Medicine, University of Rochester (NY) Medical Center.


Footnotes

Accepted for publication May 8, 1987.

Reprint requests to University of Rochester Medical Center, Nephrology Division, Strong Memorial Hospital, 601 Elmwood Ave, Rochester, NY 14642 (Dr Sloand).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Nephrolithiasis: Treatment, causes, and prevention
HALL
Cleveland Clinic Journal of Medicine 2009;76:583-591.
ABSTRACT | FULL TEXT  

Cystine calculi: challenging group of stones
Ahmed et al.
Postgrad. Med. J. 2006;82:799-801.
ABSTRACT | FULL TEXT  

Renal Stone Disease in Children
Santos-Victoriano et al.
CLIN PEDIATR 1998;37:583-599.
ABSTRACT  

Urology
Leadbetter and Gillenwater
JAMA 1991;265:3175-3176.
ABSTRACT  

Cystinuria: Failure of Captopril to Reduce Cystine Excretion
DAHLBERG and JONES
Arch Intern Med 1989;149:713-713.
ABSTRACT  

Cystinuria: Failure of Captopril to Reduce Cystine Excretion-Reply
SLOAND and Izzo
Arch Intern Med 1989;149:713-717.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.